Conditional Survival After Surgical Intervention in Patients With Non-Small Cell Lung Cancer

被引:18
|
作者
Fukui, Takayuki [1 ]
Okasaka, Toshiki [1 ]
Kawaguchi, Koji [1 ]
Fukumoto, Koichi [1 ]
Nakamura, Shota [1 ]
Hakiri, Shuhei [1 ]
Ozeki, Naoki [1 ]
Yokoi, Kohei [1 ]
机构
[1] Nagoya Univ, Grad Sch Med, Dept Thorac Surg, Nagoya, Aichi 4648601, Japan
来源
ANNALS OF THORACIC SURGERY | 2016年 / 101卷 / 05期
关键词
LONG-TERM SURVIVAL; REGISTRY;
D O I
10.1016/j.athoracsur.2015.11.067
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Conditional survival (CS) is defined as living some additional time predicated on living to a certain time point. This study aimed to evaluate the usefulness of CS analyses for postoperative follow-up of surgically treated patients with lung cancer. Methods. We retrospectively analyzed survival and clinicopathologic data from 859 patients with non-small cell lung cancer who underwent complete resection. CS is the probability of surviving additional time (y), after an individual has already survived for some time (x), and can be calculated from the following formula: CS(y vertical bar x) [ S(x + y)/S(x), where S is the overall survival at a specific time. Results. The 5-year cumulative overall survival rate was 75%. The additional 5-year survival rates at 1, 2, 3, and 4 years after operation (5Y-CS) were 75%, 77%, 77%, and 81%, respectively. The likelihood of surviving for a total of 5 years, 3 years after surgery was 89%. Age less than or equal to 70 years, female sex, no or light smoking, adenocarcinoma histologic type, pathologic stage I, and normal serum carcinoembryonic antigen levels were the clinicopathologic features associated with a high cancer-specific CS. For patients with favorable factors, the 2Y recurrence-free CS (3) reached 100%, whereas 5Y-CS did not change. Conclusions. Estimates of CS probabilities may provide more meaningful information than traditional cumulative survival. Even in patients with favorable factors, a postoperative follow-up visit after 3 postsurgical years may be required. (C) 2016 by The Society of Thoracic Surgeons
引用
收藏
页码:1877 / 1882
页数:6
相关论文
共 50 条
  • [41] Survival in non-small cell lung cancer patients with versus without prior cancer
    Akira Sato
    Toshitaka Morishima
    Masato Takeuchi
    Kayo Nakata
    Koji Kawakami
    Isao Miyashiro
    Scientific Reports, 13
  • [42] Surgical Outcomes of Patients with Locally Advanced Non-small Cell Lung Cancer
    Lushaj, E.
    Jaoude, W. Abi
    Macke, R.
    Maloney, J.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S34 - S35
  • [43] Time Trends of Surgical Outcome in Patients with Non-small Cell Lung Cancer
    Hanagiri, Takeshi
    Baba, Tetsuro
    So, Tetsuya
    Yasuda, Manabu
    Sugaya, Masakazu
    Ono, Kenji
    So, Tomoko
    Uramoto, Hidetaka
    Takenoyama, Mitsuhiro
    Yasumoto, Kosei
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (06) : 825 - 829
  • [44] Surgical Outcomes in Patients With Centrally Located Non-small Cell Lung Cancer
    Tsukioka, Takuma
    Izumi, Nobuhiro
    Komatsu, Hiroaki
    Inoue, Hidetoshi
    Matsuda, Yumi
    Ito, Ryuichi
    Kimura, Takuya
    Nishiyama, Noritoshi
    IN VIVO, 2021, 35 (05): : 2815 - 2820
  • [45] NOMOGRAM FOR PREDICTING SURVIVAL IN PATIENTS WITH RESECTED NON-SMALL CELL LUNG CANCER
    Liang, Wenhua
    Wang, Daoyuan
    Deng, Qiuhua
    Pan, Hui
    Shi, Xiaoshun
    Zhong, Chucheng
    Mo, Lili
    Wang, Jiaxuan
    He, Jianxing
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S519 - S519
  • [46] Effect of Statins and Metformin on Survival in Patients with Non-Small Cell Lung Cancer
    Duma, Narjust
    Kang, Mohleen
    Abu-Ihweij, Khaleb
    Choudhary, Moaz
    Gandhi, Arpita
    Gutierrez, Martin
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S367 - S368
  • [47] The effect of tumour laterality on survival for non-small cell lung cancer patients
    McWilliam, A.
    Osorio, E. Vasquez
    Aznar, M.
    Faivre-Finn, C.
    Van Herk, M.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S13 - S14
  • [48] The effect of tumour laterality on survival for non-small cell lung cancer patients
    McWilliam, A.
    Osorio, E. Vasquez
    Faivre-Finn, C.
    Van Herk, M.
    LUNG CANCER, 2018, 115 : S67 - S68
  • [49] SURVIVAL IN COPD PATIENTS WITH STAGE 1 NON-SMALL CELL LUNG CANCER
    Thiruchelvam, Nirosshan
    Sarda, Yash
    Han, Xiaozhen
    Wang, Xiaofeng
    Mazzone, Peter
    CHEST, 2020, 158 (04) : 1463A - 1463A
  • [50] Abasic sites and survival in resected patients with non-small cell lung cancer
    Zhao, Hua
    Shen, Jie
    Deininger, Prescott
    Hunt, Jay D.
    CANCER LETTERS, 2007, 246 (1-2) : 47 - 53